Pavonine Co Ltd (177830) - Total Liabilities
Based on the latest financial reports, Pavonine Co Ltd (177830) has total liabilities worth ₩80.81 Billion KRW (≈ $54.77 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Pavonine Co Ltd (177830) investment intensity to see how much of total assets are deployed in long-term investments.
Pavonine Co Ltd - Total Liabilities Trend (2014–2024)
This chart illustrates how Pavonine Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Pavonine Co Ltd (177830) total assets.
Pavonine Co Ltd Competitors by Total Liabilities
The table below lists competitors of Pavonine Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ATP 30 Public Company Limited
BK:ATP30
|
Thailand | ฿667.54 Million |
|
AlphaVest Acquisition Corp Ordinary Shares
NASDAQ:ATMV
|
USA | $5.26 Million |
|
SPOTLIGHT GROUP AB O.N.
F:7T7
|
Germany | €68.44 Million |
|
Nuintek Co.Ltd
KQ:012340
|
Korea | ₩58.51 Billion |
|
Millennium Group International Holdings Limited Ordinary Shares
NASDAQ:MGIH
|
USA | $11.34 Million |
|
Rathbone Brothers PLC
LSE:RAT
|
UK | GBX3.87 Billion |
|
Manganese X Energy Corp
V:MN
|
Canada | CA$628.40K |
Liability Composition Analysis (2014–2024)
This chart breaks down Pavonine Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Pavonine Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pavonine Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pavonine Co Ltd (2014–2024)
The table below shows the annual total liabilities of Pavonine Co Ltd from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩86.63 Billion ≈ $58.71 Million |
+52.14% |
| 2023-12-31 | ₩56.95 Billion ≈ $38.59 Million |
-13.27% |
| 2022-12-31 | ₩65.66 Billion ≈ $44.50 Million |
+0.28% |
| 2021-12-31 | ₩65.48 Billion ≈ $44.37 Million |
-8.49% |
| 2020-12-31 | ₩71.55 Billion ≈ $48.49 Million |
-12.66% |
| 2019-12-31 | ₩81.93 Billion ≈ $55.52 Million |
+23.33% |
| 2018-12-31 | ₩66.43 Billion ≈ $45.02 Million |
+6.98% |
| 2017-12-31 | ₩62.10 Billion ≈ $42.08 Million |
+24.48% |
| 2016-12-31 | ₩49.88 Billion ≈ $33.81 Million |
+39.78% |
| 2015-12-31 | ₩35.69 Billion ≈ $24.19 Million |
+61.88% |
| 2014-12-31 | ₩22.05 Billion ≈ $14.94 Million |
-- |
About Pavonine Co Ltd
Pavonine Co., Ltd. manufactures and sells TVs, medical devices, industrial equipment, and household appliances in South Korea and rest of Asia. The company offers TV appearance products and signage, such as the terrace external TV, digital signage, LED electric bulletin boards, electronic blackboards, curved game monitors, and kiosks. It also offers metal fittings and structures for medical devic… Read more